Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate

被引:169
作者
van Meeteren, LA
Ruurs, P
Christodoulou, E
Goding, JW
Takakusa, H
Kikuchi, K
Perrakis, A
Nagano, T
Moolenaar, WH
机构
[1] Netherlands Canc Inst, Div Cellular Biochem, NL-1066 CX Amsterdam, Netherlands
[2] Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands
[3] Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands
[4] Monash Univ, Sch Med, Dept Pathol & Immunol, Melbourne, Vic 3181, Australia
[5] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan
关键词
D O I
10.1074/jbc.M413183200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Autotaxin (ATX) or nucleotide pyrophosphatase/ phosphodiesterase 2 (NPP2) is an NPP family member that promotes tumor cell motility, experimental metastasis, and angiogenesis. ATX primarily functions as a lysophospholipase D, generating the lipid mediator lysophosphatidic acid (LPA) from lysophosphatidylcholine. ATX uses a single catalytic site for the hydrolysis of both lipid and non-lipid phosphodiesters, but its regulation is not well understood. Using a new fluorescence resonance energy transfer-based phosphodiesterase sensor that reports ATX activity with high sensitivity, we show here that ATX is potently and specifically inhibited by LPA and sphingosine 1-phosphate (S1P) in a mixed-type manner (K-i similar to 10(-7) M). The homologous ecto-phosphodiesterase NPP1, which lacks lysophospholipase D activity, is insensitive to LPA and S1P. Our results suggest that, by repressing ATX activity, LPA can regulate its own biosynthesis in the extracellular environment, and they reveal a novel role for S1P as an inhibitor of ATX, in addition to its well established role as a receptor ligand.
引用
收藏
页码:21155 / 21161
页数:7
相关论文
共 35 条
  • [1] Developmental expression analysis of murine autotaxin (ATX)
    Bächner, D
    Ahrens, M
    Betat, N
    Schröder, D
    Gross, G
    [J]. MECHANISMS OF DEVELOPMENT, 1999, 84 (1-2) : 121 - 125
  • [2] Plasma lysophosphatidic acid concentration and ovarian cancer
    Baker, DL
    Morrison, P
    Miller, B
    Riely, CA
    Tolley, B
    Westermann, AM
    Bonfrer, JMG
    Bais, E
    Moolenaar, WH
    Tigyi, G
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (23): : 3081 - 3082
  • [3] Nucleotide pyrophosphatases/phosphodiesterases on the move
    Bollen, M
    Gijsbers, R
    Ceulemans, H
    Stalmans, W
    Stefan, C
    [J]. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2000, 35 (06) : 393 - 432
  • [4] Clair T, 2003, CANCER RES, V63, P5446
  • [5] Nucleotide binding to autotaxin: Crosslinking of bound substrate followed by lysC digestion identifies two labeled peptides
    Clair, T
    Krutzsch, HC
    Liotta, LA
    Stracke, ML
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 236 (02) : 449 - 454
  • [6] Autotaxin is an exoenzyme possessing 5'-nucleotide phosphodiesterase/ATP pyrophosphatase and ATPase activities
    Clair, T
    Lee, HY
    Liotta, LA
    Stracke, ML
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (02) : 996 - 1001
  • [7] Characterization of plasma unsaturated lysophosphatidylcholines in human and rat
    Croset, M
    Brossard, N
    Polette, A
    Lagarde, M
    [J]. BIOCHEMICAL JOURNAL, 2000, 345 : 61 - 67
  • [8] THE BIOACTIVE PHOSPHOLIPID LYSOPHOSPHATIDIC ACID IS RELEASED FROM ACTIVATED PLATELETS
    EICHHOLTZ, T
    JALINK, K
    FAHRENFORT, I
    MOOLENAAR, WH
    [J]. BIOCHEMICAL JOURNAL, 1993, 291 : 677 - 680
  • [9] Fuss B, 1997, J NEUROSCI, V17, P9095
  • [10] The hydrolysis of lysophospholipids and nucleotides by autotaxin (NPP2) involves a single catalytic site
    Gijsbers, R
    Aoki, J
    Arai, H
    Bollen, M
    [J]. FEBS LETTERS, 2003, 538 (1-3) : 60 - 64